Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses.

Antimicrobial Agents and Chemotherapy
P J MorrisonR L Kunka

Abstract

The pharmacokinetics of five dose levels of lomefloxacin (100, 200, 400, 600, and 800 mg) were examined in a single-dose, double-blind, placebo-controlled study involving 40 subjects. There were eight subjects in each group: five received active drug and three received placebo; each subject was given only one dose. All subjects completed the study, and lomefloxacin was well tolerated at all doses. No drug crystals were noted in the urine at 3 and 6 h after the dose. The mean maximum concentration in serum (Cmax) ranged from 1.11 to 7.46 micrograms/ml for the 100- to 800-mg doses, respectively, and the AUC increased proportionally with the dose. The mean time to Cmax (Tmax) values averaged 64.8 +/- 28.8 min. The elimination half-life and plasma clearance averaged 7.7 +/- 0.52 h and 259 +/- 37 ml/min, respectively. Mean concentrations in urine were highest during the first 4 h after the dose and ranged from 104 to 713 micrograms/ml following the 100- and 800-mg doses, respectively. Concentrations above 20 micrograms/ml in urine were observed in most subjects over 24 h at the three lower doses and averaged over 120 micrograms/ml during the 12- to 24-h interval at the 400-mg dose, thus supporting once-per-day dosing. Excretion rate...Continue Reading

References

Jan 1, 1986·Antimicrobial Agents and Chemotherapy·T A TartaglioneT M Kerkering
Jan 1, 1986·Chemotherapy·S B ThorsteinssonR Holm
Jun 1, 1987·Antimicrobial Agents and Chemotherapy·T HiroseS Mitsuhashi
Sep 1, 1987·Antimicrobial Agents and Chemotherapy·H LodeP Koeppe
Feb 1, 1983·Antimicrobial Agents and Chemotherapy·B N SwansonR K Ferguson
Sep 1, 1984·The Journal of Antimicrobial Chemotherapy·R WiseZ N Adhami
Sep 1, 1984·The Journal of Antimicrobial Chemotherapy·R WolfJ Latts

❮ Previous
Next ❯

Citations

Aug 21, 1992·Pharmaceutisch Weekblad. Scientific Edition·R Janknegt
Aug 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C S LewinJ T Smith
Apr 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J S Wolfson, D C Hooper
Mar 1, 1989·Diagnostic Microbiology and Infectious Disease·T L Hunt, M A Adams
May 1, 1989·Diagnostic Microbiology and Infectious Disease·K E AldridgeC V Sanders
May 1, 1989·Diagnostic Microbiology and Infectious Disease·H TrujilloC Gomez
May 1, 1989·Diagnostic Microbiology and Infectious Disease·M J RobbinsR N Grüneberg
May 1, 1992·Diagnostic Microbiology and Infectious Disease·D Felmingham, M J Robbins
Dec 1, 1992·International Journal of Antimicrobial Agents·G Amaya-TapiaE Rodriguez-Noriega
Dec 1, 1992·International Journal of Antimicrobial Agents·W H SetoC Carillo
Jan 1, 1993·International Journal of Antimicrobial Agents·R R BaileyP General
Jan 1, 1993·International Journal of Antimicrobial Agents·W CullmannA Braunsteiner
Aug 1, 1996·Nuclear Medicine and Biology·T J TewsonP Frank
Feb 1, 1996·Journal of Photochemistry and Photobiology. B, Biology·A R YoungJ L Hawk
Dec 12, 2003·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·J L C M DorneA G Renwick
Jul 20, 2002·International Journal of Antimicrobial Agents·Kurt G Naber, UNKNOWN European Lomefloxacin Prostatitis Study Group
Jul 1, 1989·Antimicrobial Agents and Chemotherapy·D E NixJ J Schentag
Aug 1, 1989·Antimicrobial Agents and Chemotherapy·J SegretiG M Trenholme
Jan 1, 1990·Antimicrobial Agents and Chemotherapy·A LeroyG Humbert
Dec 1, 1990·Antimicrobial Agents and Chemotherapy·R A BlumJ J Schentag
Dec 1, 1990·Antimicrobial Agents and Chemotherapy·J M KovarikJ Verhoef
Jun 1, 1990·Antimicrobial Agents and Chemotherapy·C Rustige, B Wiedemann
May 1, 1995·Antimicrobial Agents and Chemotherapy·H StuhtT Schaberg
Apr 6, 1992·The American Journal of Medicine·A OnE G Maderazo
Apr 6, 1992·The American Journal of Medicine·K H Mayer, J A Ellal
Apr 6, 1992·The American Journal of Medicine·T G Mant
Aug 1, 1990·Biopharmaceutics & Drug Disposition·I S Morse
Oct 21, 2017·International Journal of Molecular Sciences·Artur BeberokEwa Buszman
Mar 2, 2019·Drug and Chemical Toxicology·Virginia TzankovaBorislav Tzankov
Oct 1, 1989·Clinical Microbiology Reviews·J S Wolfson, D C Hooper

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.